AU2016204196A1 - Methods, compositions and apparatuses for facilitating regeneration - Google Patents

Methods, compositions and apparatuses for facilitating regeneration

Info

Publication number
AU2016204196A1
AU2016204196A1 AU2016204196A AU2016204196A AU2016204196A1 AU 2016204196 A1 AU2016204196 A1 AU 2016204196A1 AU 2016204196 A AU2016204196 A AU 2016204196A AU 2016204196 A AU2016204196 A AU 2016204196A AU 2016204196 A1 AU2016204196 A1 AU 2016204196A1
Authority
AU
Australia
Prior art keywords
cells
functional
apparatuses
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016204196A
Inventor
Lewis S. Gruber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siwa Corp
Original Assignee
Siwa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2014202548A external-priority patent/AU2014202548A1/en
Application filed by Siwa Corp filed Critical Siwa Corp
Priority to AU2016204196A priority Critical patent/AU2016204196A1/en
Publication of AU2016204196A1 publication Critical patent/AU2016204196A1/en
Abandoned legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

Apparatuses, compositions and methods for removing cells which interfere with regenerative processes. The apparatuses, compositions and methods selectively kill partially functional and/or non-functional cells versus functional cells while protecting functional proliferative cells to the extent that, upon removal of the killed cells by disintegration or scavenging, functional cells replace the partially- or non-functional cells. 7884143_1 (GHMatters) P85635.AU.2
AU2016204196A 2008-05-23 2016-06-21 Methods, compositions and apparatuses for facilitating regeneration Abandoned AU2016204196A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2016204196A AU2016204196A1 (en) 2008-05-23 2016-06-21 Methods, compositions and apparatuses for facilitating regeneration

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61/055,846 2008-05-23
AU2014202548A AU2014202548A1 (en) 2008-05-23 2014-05-12 Methods, compositions and apparatuses for facilitating regeneration
AU2016204196A AU2016204196A1 (en) 2008-05-23 2016-06-21 Methods, compositions and apparatuses for facilitating regeneration

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2014202548A Division AU2014202548A1 (en) 2008-05-23 2014-05-12 Methods, compositions and apparatuses for facilitating regeneration

Publications (1)

Publication Number Publication Date
AU2016204196A1 true AU2016204196A1 (en) 2016-07-14

Family

ID=56682311

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016204196A Abandoned AU2016204196A1 (en) 2008-05-23 2016-06-21 Methods, compositions and apparatuses for facilitating regeneration

Country Status (1)

Country Link
AU (1) AU2016204196A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9993535B2 (en) 2014-12-18 2018-06-12 Siwa Corporation Method and composition for treating sarcopenia
US10226531B2 (en) 2010-09-27 2019-03-12 Siwa Corporation Selective removal of age-modified cells for treatment of atherosclerosis
US10358502B2 (en) 2014-12-18 2019-07-23 Siwa Corporation Product and method for treating sarcopenia
US10858449B1 (en) 2017-01-06 2020-12-08 Siwa Corporation Methods and compositions for treating osteoarthritis
US10889634B2 (en) 2015-10-13 2021-01-12 Siwa Corporation Anti-age antibodies and methods of use thereof
US10919957B2 (en) 2017-04-13 2021-02-16 Siwa Corporation Humanized monoclonal advanced glycation end-product antibody
US10995151B1 (en) 2017-01-06 2021-05-04 Siwa Corporation Methods and compositions for treating disease-related cachexia
US11518801B1 (en) 2017-12-22 2022-12-06 Siwa Corporation Methods and compositions for treating diabetes and diabetic complications

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10226531B2 (en) 2010-09-27 2019-03-12 Siwa Corporation Selective removal of age-modified cells for treatment of atherosclerosis
US9993535B2 (en) 2014-12-18 2018-06-12 Siwa Corporation Method and composition for treating sarcopenia
US10358502B2 (en) 2014-12-18 2019-07-23 Siwa Corporation Product and method for treating sarcopenia
US11873345B2 (en) 2014-12-18 2024-01-16 Siwa Corporation Product and method for treating sarcopenia
US10889634B2 (en) 2015-10-13 2021-01-12 Siwa Corporation Anti-age antibodies and methods of use thereof
US10858449B1 (en) 2017-01-06 2020-12-08 Siwa Corporation Methods and compositions for treating osteoarthritis
US10995151B1 (en) 2017-01-06 2021-05-04 Siwa Corporation Methods and compositions for treating disease-related cachexia
US10919957B2 (en) 2017-04-13 2021-02-16 Siwa Corporation Humanized monoclonal advanced glycation end-product antibody
US11518801B1 (en) 2017-12-22 2022-12-06 Siwa Corporation Methods and compositions for treating diabetes and diabetic complications

Similar Documents

Publication Publication Date Title
MX342994B (en) Methods, compositions and apparatuses for facilitating regeneration.
AU2016204196A1 (en) Methods, compositions and apparatuses for facilitating regeneration
EA201001329A1 (en) COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS
WO2009126786A3 (en) Improved quenching methods for red blood cell pathogen inactivation
NZ588104A (en) Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
TN2011000239A1 (en) Hsp90 inhibitor combinations
WO2011049988A3 (en) Indazoles to treat flaviviridae virus infection
MX350773B (en) Methods and compositions for weed control.
UA116093C2 (en) Methods and compositions for weed control
WO2008030367A3 (en) Selective myostatin inhibitors
MX2010002317A (en) Substituted indole derivatives and methods of use thereof.
MX2011010202A (en) Method for reducing sunburn damage in plants.
MX2011008602A (en) Methods of treating hair related conditions.
MX2008013196A (en) 5-amido-2-carboxamide indoles.
HK1133394A1 (en) Method to enhance tissue regeneration
EA201100424A1 (en) NEW INHIBITORS
PH12013500094A1 (en) Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene a4 hydrolase
WO2011017132A3 (en) Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
WO2009070693A3 (en) Modulators of ocular oxidative stress
WO2008112647A3 (en) Nitroxide radical as a treatment for neurodegeneration
MX348514B (en) Potentiated biocidal compositions and methods of use.
EP2035015A4 (en) Compositions, methods, and kits for treating dry eye
SI2819516T1 (en) Use of (1r,5s)-(+)-1-(naphthalen-2-yl)-3-azabicyclo(3.1.0)hexane in the treatment of conditions affected by monoamine neurotransmitters
EP4070794A3 (en) Methods of use cyclic amide derivatives to treat sigma receptor-mediated disorders
MX2010012593A (en) Methods for treating injury associated with exposure to an alkylating species.

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted